Venmax Drugs and Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 1.081 million compared to INR 1.018 million a year ago. Net loss was INR 1.149 million compared to INR 2.068 million a year ago. Basic loss per share was INR 0.22 compared to INR 0.39 a year ago. For the full year, total revenue was INR 4.730 million compared to INR 1.555 million a year ago. Net loss was INR 2.736 million compared to INR 2.373 million a year ago. Basic loss per share was INR 0.52 compared to INR 0.45 a year ago.